GNOM241220P6000
- 0.00
- 0.000.00%
Global X Fds Genomics & Biotechnology Etf Newsroom
Weekly Buzz: Tech stocks hit high scores on ominous day
Catalyst Watch: FOMC Meeting, Govt. Funding Drama, Earnings for Micron, Nike, and FedEx
Solid Biosciences Positioned For Next-Gen Duchenne Muscular Dystrophy Treatment Success: Analyst
Agilent Technologies Analyst Ratings
Market Mixed on Friday the 13th | Livestock
Natera Analyst Ratings
Thursday Ends in Index Declines | Wall Street Today
Market Falls Thursday, Producer Inflation Grows, and Tech Pulls Back From Records | LiveStock
Natera Announces Enrollment Of First Patients In SAGITTARIUS A Randomized Phase III Clinical Trial In Colon Cancer; ~700-900 Patients Expected To Be Enrolled Across More Than 20 Sites
Bio-Techne and MedSanTek Team Up to Boost Research in Turkey and Azerbaijan
Arrowhead Pharma Analyst Ratings
Market Climbs on CPI Inflation and Likelihood of Rate Cuts | Livestock
BioNTech Analyst Ratings
This D.R. Horton Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Arrowhead Pharmaceuticals Announced Interim Results From A Phase 1/2A Clinical Study Of ARO-CFB, The Company's Investigational RNA Interference (RNAi) Therapeutic Targeting Complement Factor B Being Developed As A Potential Treatment For Complement...
Illumina Analyst Ratings
Market Falls Wednesday, but Googles Chip Impresses | WST
Google's Quantum Chip Might Have Contacted Parallel Universes | Live Stock
CRISPR Therapeutics Analyst Ratings
Qiagen Analyst Ratings